This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Atropine Injection BP 0.4MG/ML (2015-11-19)
- Starting date:
- November 19, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-55944
Affected Products
Atropine Injection BP 0.4MG/ML
Reason
One lot of Atropine Injection BP 0.4 mg/mL (DIN 02094681) (L) 50187 marketed and sold by Alveda Pharmaceuticals Inc. is being recalled, due to an incorrect barcode on the ampoule label. The barcode reads (01)00837641000591 which is that same barcode as on the ampoule label of Alveda Epinephrine Injection USP 1 mg/mL (DIN 02325225).
Depth of distribution
Wholesalers and sub-recall to physicians, hospitals and hospital Pharmacists in Alberta, British Columbia, Ontario, New Brunswick, Newfoundland, Nova Scotia, Manitoba, Quebec, and Saskatchewan.
Affected products
Atropine Injection BP 0.4MG/ML
DIN, NPN, DIN-HIM
DIN 02094681Dosage form
Solution
Strength
Atropine sulfate 0.4 mg/mL
Lot or serial number
50187
Companies
- Recalling Firm
-
Alveda Pharmaceutical Inc.
Suite 1100, 21 St. Clair Avenue East,
Toronto
M4T 1L9
Ontario
CANADA
- Marketing Authorization Holder
-
Alveda Pharmaceutical Inc.
Suite 1100, 21 St. Clair Avenue East,
Toronto
M4T 1L9
Ontario
CANADA